<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20231203060248N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2023-12-23</date_registration>
      <primary_sponsor>Bagheiat-allah University of Medical Sciences</primary_sponsor>
      <public_title>The effectiveness of transitional care program on the quality of life of women with breast cancer and the care burden of their caregivers</public_title>
      <acronym></acronym>
      <scientific_title>Effectiveness of transitional care program from hospital to home on the quality of life of women with breast cancer their family caregiver’s burden</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2024-04-20</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>60</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/74157</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Supportive, Randomization description: This study is a randomized controlled clinical trial that will be conducted on women undergoing mastectomy in selected military centers. At first, the samples will be randomly divided into intervention and control groups based on the inclusion criteria and selected in a purposeful way and by the quadruple block method. The method of random assignment with blocks of four will be such that letter A will be assigned to the intervention group and letter B will be assigned to the control group, and in blocks of four with letters A and B, six states AABB, BBAA, ABAB, BABA , ABBA, BAAB will be written on separate sheets and thrown in a container. Randomly, one of these sheets will be taken out of the container and the composition written on it will be noted and that sheet will be thrown into the container again. Since the sample size is 60 patients, this procedure will be repeated fifteen times and each time the composition written on the sheet will be noted down after the composition written on the previous sheet. Then, each letter will be assigned a number from one to sixty in the order of the letters written down one after the other. Each of the letters will be placed in an envelope and numbers from one to sixty will be written on the envelope. Each time a patient is selected, one of these envelopes will be opened in order of the number written on the envelope, and it will be determined in which group the patient will be placed.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Breast Cancer.</hc_freetext>
      <i_freetext>Intervention 1: For the intervention group, a structured transitional care program based on these principles will be developed. The program will include four components:1. Preparation for transition:Pre-discharge education on the discharge process, expectations for home care, differences between hospital and home care, and the psychological and physical preparation of patients and caregivers.2. Support and independence:Aims to reduce dependency and increase caregiver and patient self-efficacy through structured education, emotional support, and caregiver participation in providing care.3. How to communicate with the care team4. Integrated and needs-based care:Includes a comprehensive assessment of patient and caregiver needs, personalized care planning, ongoing follow-up, targeted education, and access to support services.The educational content will be delivered by a trained nurse with experience in oncology (researcher) in four sessions (one in person before discharge and three weekly sessions by telephone after discharge, for 45 minutes).In addition to the educational sessions, participants will receive two home visits (at weeks 4 and 8) and weekly telephone follow-ups to assess clinical symptoms, psychosocial status, caregiver needs, and provide tailored counseling. During the home visits, the patients' clinical status (vital signs, blood glucose, weight, mobility, respiratory and mental status) will be monitored and recorded. Intervention 2: The control group will receive routine postoperative care as directed.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
All data is shared after de-identifying individuals

When:
Six months after the results are published

To whom:
Everyone will have access to educational content

Conditions:
Access to the outcomes and results of this study will help others to use transitional care to choose the most effective work on the quality of life of women with breast cancer and the care burden of their caregivers.

Where to obtain:
To receive the data, send an email to the address below
 marziealighadr25@gmail.com

How to obtain:
Correspond by email

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Marzieh Sadat Seyyed Aliqader</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Sheikh Bahai South, Nosrati Street, Baqiyatullah Aj University of Medical Sciences</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1435916471</zip>
        <telephone>+98 21 6448 2797</telephone>
        <email>marziealighadr25@gmail.com</email>
        <affiliation>Bagheiat-allah University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Marzieh Sadat Seyyed Aliqader</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Sheikh Bahai South, Nosrati Street, Baqiyatullah Aj University of Medical Sciences</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1435916471</zip>
        <telephone>+98 21 6448 2797</telephone>
        <email>marziealighadr25@gmail.com</email>
        <affiliation>Bagheiat-allah University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Hospitalized patients who are on postoperative days 1 to 3 following mastectomy surgery.
Breast cancer identified by pathology and treated by surgery
Ability to complete the questionnaire independently
Access to home and mobile phones
Residence in Tehran and its suburbs within one month after discharge for the possibility of home visits
No mental illness</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>70 years</agemax>
      <gender>Female</gender>
      <exclusion_criteria>History of chronic diseases
Women over seventy years old
Non-residence of the person in Tehran</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>C50.9</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Malignant neoplasm of breast of unspecified site</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Other</i_code>
      <i_code>Other</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>For the intervention group, a structured transitional care program based on these principles will be developed. The program will include four components:1. Preparation for transition:Pre-discharge education on the discharge process, expectations for home care, differences between hospital and home care, and the psychological and physical preparation of patients and caregivers.2. Support and independence:Aims to reduce dependency and increase caregiver and patient self-efficacy through structured education, emotional support, and caregiver participation in providing care.3. How to communicate with the care team4. Integrated and needs-based care:Includes a comprehensive assessment of patient and caregiver needs, personalized care planning, ongoing follow-up, targeted education, and access to support services.The educational content will be delivered by a trained nurse with experience in oncology (researcher) in four sessions (one in person before discharge and three weekly sessions by telephone after discharge, for 45 minutes).In addition to the educational sessions, participants will receive two home visits (at weeks 4 and 8) and weekly telephone follow-ups to assess clinical symptoms, psychosocial status, caregiver needs, and provide tailored counseling. During the home visits, the patients' clinical status (vital signs, blood glucose, weight, mobility, respiratory and mental status) will be monitored and recorded.</i_keyword>
      <i_keyword>The control group will receive routine postoperative care as directed</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Quality of Life. Timepoint: before the start of the intervention and three months after the intervention. Method of measurement: The European Organization for Research and Treatment of Cancer Quality of Life Questionnaire–Breast Cancer Module (EORTC QLQ-BR30).</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>The care burden of the caregivers. Timepoint: before the start of the intervention and three months after the intervention. Method of measurement: Zarit Care Burden Assessment Questionnaire.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Bagheiat-allah University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2023-10-24</approval_date>
        <contact_name>Ethics and Research Committee of Baqiyatullah Azam Educational-Therapeutic Center</contact_name>
        <contact_address>South Bahai Sheikh, Nosrati Alley, Baqiyatullah Aj University of Medical Sciences Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
